Breaking News

KCAS Acquires FlowMetric

Accelerates growth as CRO for outsourced cell and gene therapy programs.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Continuing to deliver against both growth objectives and more integrated customer service offerings, KCAS has acquired FlowMetric, LLC, a provider of flow cytometry and cellular assay R&D services to biotech, pharmaceutical and cell/gene therapy industries. Financial terms of the transaction were not disclosed. KCAS is a U.S.-based contract research organization (CRO) providing GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and cell...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters